# Safety and Activity of F14 for Management of Pain Following Total Knee Replacement

> **NCT03541655** · PHASE2 · COMPLETED · sponsor: **Arthritis Innovation Corporation** · enrollment: 20 (actual)

## Conditions studied

- Total Knee Replacement
- Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine HCl
- **DRUG:** F14 (celecoxib)

## Key facts

- **NCT ID:** NCT03541655
- **Lead sponsor:** Arthritis Innovation Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-04
- **Primary completion:** 2019-06-20
- **Final completion:** 2020-03-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541655, "Safety and Activity of F14 for Management of Pain Following Total Knee Replacement". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT03541655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*